Chronic Hepatitis B: Tenofovir and Entecavir compared

被引:0
|
作者
Kessing, Richard
机构
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2020年 / 58卷 / 09期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Comparison of the Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B
    Guzelbulut, Fatih
    Ovunc, Ayse Oya Kurdas
    Cetinkaya, Zuleyha Akkan
    Senates, Ebubekir
    Gokden, Yasemin
    Salturk, Ayca Gokcen Degirmenci
    Sezikli, Mesut
    Ozkara, Selvinaz
    Cetinkaya, Fuat
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 477 - 480
  • [2] Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
    Lee, S.
    Ahn, S. H.
    Jung, K. S.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Baatarkhuu, O.
    Ku, H. J.
    Han, K.
    Park, J. Y.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (02) : 141 - 147
  • [3] Tenofovir is associated with a better prognosis of hepatocellular carcinoma compared with entecavir in patients with chronic hepatitis B
    Um, Hyun Jun
    Choi, Jonggi
    Lim, Young-Suk
    Choi, Won-Mook
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1130 - S1131
  • [4] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir?
    Kamal, Faisal
    Khan, Muhammad Ali
    GASTROENTEROLOGY, 2020, 158 (08) : 2311 - 2312
  • [5] Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir
    Ridruejo, Ezequiel
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (23) : 7169 - 7180
  • [6] Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir
    Ezequiel Ridruejo
    World Journal of Gastroenterology, 2014, (23) : 7169 - 7180
  • [7] TENOFOVIR VERSUS TENOFOVIR PLUS ENTECAVIR FOR CHRONIC HEPATITIS B WITH LAMIVUDINE-RESISTANCE AND ENTECAVIR-RESISTANCE
    Lee, S.
    Ahn, S. H.
    Jung, K. S.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Baatarkhuu, O.
    Ku, H. J.
    Han, K-H
    Park, J. Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S595 - S595
  • [8] Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B
    Hagiwara, Satoru .
    Nishida, Naoshi
    Ida, Hiroshi
    Ueshima, Kazuomi
    Minami, Yasunori
    Takita, Masahiro
    Komeda, Yoriaki
    Kudo, Masatoshi
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (10) : 1804 - 1810
  • [9] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir? Reply
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    GASTROENTEROLOGY, 2020, 158 (08) : 2312 - 2313
  • [10] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87